พื้นที่โฆษณา

All News from PR Newswire

Thai PR News

PR Newswire

PR Newswire

CISION PR Newswire - Appian Unveils Latest Platform Release for Faster, More Powerful Data Fabric and AI Experience
PR Newswire - Appian Unveils Latest Platform Release for Faster,...

SYDNEY, March 10, 2025 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the latest versi...

By PR Newswire | Mar 10, 25
PR Newswire - AIM Vaccine's Iteratively Upgraded Diploid Rabies ...

HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine co...

By PR Newswire | Mar 10, 25
CISION PR Newswire - U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
PR Newswire - U.S. FDA approves Celltrion's OMLYCLO® (omalizumab...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA R...

By PR Newswire | Mar 10, 25
CISION PR Newswire - China Telecom and Partners Innovate Together! 5G UAV Medical Delivery Network Wins Global Mobile Award
PR Newswire - China Telecom and Partners Innovate Together! 5G U...

HONG KONG, March 10, 2025 /PRNewswire/ -- On March 5, during the 2025 Mobile World Congress (MWC25),...

By PR Newswire | Mar 10, 25
CISION PR Newswire - Webull Singapore launches trading competition for Singapore traders
PR Newswire - Webull Singapore launches trading competition for ...

SINGAPORE, March 10, 2025 /PRNewswire/ -- Webull Securities (Singapore) Pte Ltd ("Webull Sing...

By PR Newswire | Mar 10, 25
PR Newswire - RiboX Therapeutics Announces First Patient Dosed i...

PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopha...

By PR Newswire | Mar 10, 25
CISION PR Newswire - Thai Scientists from Chula to Investigate Global Warming in Antarctica
PR Newswire - Thai Scientists from Chula to Investigate Global W...

BANGKOK, March 10, 2025 /PRNewswire/ -- Prof. Dr. Suchana Chavanich from the Department of Marine Sc...

By PR Newswire | Mar 10, 25
CISION PR Newswire - HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE
PR Newswire - HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND ...

Strategic partnership strengthens regulatory compliance across HashKey Global's international exchan...

By PR Newswire | Mar 10, 25
CISION PR Newswire - Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia
PR Newswire - Doer Biologics Completes Enrollment of the Phase 2...

HANGZHOU, China, March 10, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"...

By PR Newswire | Mar 10, 25
CISION PR Newswire - HD Hyundai Executive Vice Chairman Chung Kisun meets with Palantir CEO Alex Karp to discuss 'AI Shipyard'
PR Newswire - HD Hyundai Executive Vice Chairman Chung Kisun mee...

SEOUL, South Korea, March 10, 2025 /PRNewswire/ -- HD Hyundai Executive Vice Chairman Chung K...

By PR Newswire | Mar 10, 25
PR Newswire - Collinson International partners with China Ping A...

The partnership provides Collinson International's SmartDelay™ solution as a complimentary benefit ...

By PR Newswire | Mar 10, 25
CISION PR Newswire - Huawei Launches AI-Centric 5.5G Solutions to Ignite the Mobile AI Era
PR Newswire - Huawei Launches AI-Centric 5.5G Solutions to Ignit...

SHENZHEN, China, March 10, 2025 /PRNewswire/ -- At the Huawei Product & Solution Launch during M...

By PR Newswire | Mar 10, 25
Total : 33,944 Posts
1 ... 1846 1847 1848 ... 2829
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thai PR News.
พื้นที่โฆษณา